Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Teva Pharmaceuticals USA Inc.

Division of Teva Pharmaceutical Industries Ltd.
www.tevausa.com

Latest From Teva Pharmaceuticals USA Inc.

Biosimilar Litigation Settlement Score Card: Genentech-Pfizer Herceptin Agreement Is 10th Deal

Genentech inks second settlement of trastuzumab biosimilar litigation; suits ongoing against Amgen, Celltrion/Teva, and Samsung with joint claim construction proceedings.

United States BioPharmaceutical

US Supreme Court Struggles With Post-Sale Patent Questions

During oral argument in Helsinn v. Teva, several justices seemed skeptical of making a distinction between public and private sales of an invention in assessing its patentability.

Intellectual Property Legal Issues

Gilead False Claims Case: Government Opposes Supreme Court Review But Thinks Suit Should Be Tossed

US Solicitor General says facts lacking on what government knew about alleged product misrepresentations; FDA may be burdened with discovery requests if suit proceeds to discovery and trial.

Legal Issues Manufacturing

Brand Vs. Generic Supreme Court Fight: Does Sale Of Secret Invention Bar Its Patenting?

In case with potentially broad ramifications for biopharma partnerships, high court will hear arguments Dec. 4 on whether America Invents Act changed the "on-sale bar" to patentability to allow inventions that are sold to be patented if their details are not publicly disclosed.

Legal Issues Intellectual Property
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Cancer
  • Gynecological, Urological
  • Neurology, Nervous System
  • Respiratory, Pulmonary
  • Alias(es)
  • Teva Pharmaceuticals USA
  • Biocraft Laboratories Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Teva Pharmaceutical Industries Ltd.
  • Senior Management
  • Allan Oberman, Pres. & CEO
  • Contact Info
  • Teva Pharmaceuticals USA Inc.
    Phone: (888) 838-2872
    1090 Horsham Rd.
    N. Wales, PA 19454
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register